Tracking the CNTB option chain helps you see every strike and expiry on Connect Biopharma Holdings Ltd in one view, so you can quickly identify the contracts that fit your thesis and your risk. Connect Biopharma Holdings Ltd's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of CNTB options activity at a glance. Use our scanner to monitor the CNTB option chain in real time and filter for the CNTB options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For CNTB stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the CNTB option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where CNTB stock options are being actively traded and where they are not.
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for the treatment of inflammatory allergic diseases, such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. Its products also comprise CBP-307, a small molecule modulator of sphingosine 1-phosphate receptor 1, a regulator of T cell mobilization out of lymph nodes into the periphery that is in Phase II for the treatment of autoimmune-related inflammation diseases; CBP-174, a small molecule histamine receptor 3 antagonist for oral administration, which is in a preclinical stage to treat chronic itch associated with skin inflammation; and CBP-233, a preclinical stage humanized antibody against interleukin-33, a cytokine involved in T helper 2 inflammation.
The company was founded in 2012 and is headquartered in Taicang, China.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Connect Biopharma Holdings Ltd's full chain across every expiry, highlights the most liquid strikes, and lets you screen CNTB options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of CNTB stock options — let the full option chain come to you, pre-filtered and ready to trade.
